PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model
about
CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.Endothelin-Type A receptors mediate pain in a mouse model of sickle cell disease.Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.Sickle cell disease: a natural model of acute and chronic pain.
P2860
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model
@en
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model.
@nl
type
label
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model
@en
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model.
@nl
prefLabel
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model
@en
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model.
@nl
P2093
P2860
P356
P1476
PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model
@en
P2093
Diana J Wilkie
Jonathan Nazari
Joseph DeSimone
Robert E Molokie
Zaijie Jim Wang
P2860
P304
P356
10.1172/JCI86165
P407
P577
2016-06-27T00:00:00Z